生长激素缺乏症-话题@MedSci

#生长激素缺乏症#

9篇内容 | 845人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1201411, encodeId=6ec91201411d6, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, objectTitle=欧洲监管机构对Sogroya（somapacitan）治疗成人生长激素缺乏症持积极意见, objectType=article, longId=206440, objectId=319320644031, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021130/1611971428748_5295902.jpeg, objectUrl=/article/show_article.do?id=319320644031, replyNumber=0, likeNumber=51, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=319320644031, moduleTitle=欧洲监管机构对Sogroya（somapacitan）治疗成人生长激素缺乏症持积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=319320644031)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201410, encodeId=51af12014106a, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, objectTitle=成人生长激素缺乏症诊治专家共识（2020版）, objectType=guider, longId=13062, objectId=b35621c0020a2362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=b35621c0020a2362, replyNumber=0, likeNumber=42, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b35621c0020a2362, moduleTitle=成人生长激素缺乏症诊治专家共识（2020版）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=b35621c0020a2362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201409, encodeId=22ef1201409df, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, objectTitle=针对生长激素缺乏症（GHD），FDA为Somatrogon发出了完整的回复信（CRL）, objectType=article, longId=294566, objectId=8e112945669d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2022123/1642913645634_5295902.jpg, objectUrl=/article/show_article.do?id=8e112945669d, replyNumber=0, likeNumber=56, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e112945669d, moduleTitle=针对生长激素缺乏症（GHD），FDA为Somatrogon发出了完整的回复信（CRL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e112945669d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1201408, encodeId=2f69120140860, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, objectTitle=《过渡期生长激素缺乏症诊断及治疗专家共识》解读, objectType=guider, longId=15640, objectId=e69051c0023001d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=e69051c0023001d9, replyNumber=0, likeNumber=57, createdTime=2022-03-10, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e69051c0023001d9, moduleTitle=《过渡期生长激素缺乏症诊断及治疗专家共识》解读, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=e69051c0023001d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=901181, encodeId=69d790118117, content=学习了<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, objectTitle=2020 KES/KSPE立场声明：生长激素缺乏的诊断和治疗, objectType=guider, longId=11959, objectId=923051c0019320f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=923051c0019320f9, replyNumber=0, likeNumber=91, createdTime=2020-11-22, rootId=0, userName=124fad42m35暂无昵称, userId=c0472529402, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=923051c0019320f9, moduleTitle=2020 KES/KSPE立场声明：生长激素缺乏的诊断和治疗, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=923051c0019320f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=895338, encodeId=745b895338d8, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, objectTitle=2020 KES/KSPE立场声明：生长激素缺乏的诊断和治疗, objectType=guider, longId=11959, objectId=923051c0019320f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=923051c0019320f9, replyNumber=0, likeNumber=79, createdTime=2020-10-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=923051c0019320f9, moduleTitle=2020 KES/KSPE立场声明：生长激素缺乏的诊断和治疗, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=923051c0019320f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=895337, encodeId=351c89533e10, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, objectTitle=过渡期生长激素缺乏症诊断及治疗专家共识, objectType=guider, longId=12013, objectId=95b3d1c00193ea9d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=95b3d1c00193ea9d, replyNumber=0, likeNumber=108, createdTime=2020-10-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95b3d1c00193ea9d, moduleTitle=过渡期生长激素缺乏症诊断及治疗专家共识, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=95b3d1c00193ea9d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=895336, encodeId=647889533618, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, objectTitle=长效生长激素Somatrogon治疗生长激素缺乏症儿童，日本3期临床成功, objectType=article, longId=195624, objectId=fdb21956248b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/adhd_children_s22a_adhd_symptoms.jpg, objectUrl=/article/show_article.do?id=fdb21956248b, replyNumber=0, likeNumber=0, createdTime=2020-10-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdb21956248b, moduleTitle=长效生长激素Somatrogon治疗生长激素缺乏症儿童，日本3期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdb21956248b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=882427, encodeId=e0d388242ef6, content=有点confused，请问生长激素缺乏症是不是就是呆小症？<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>🤔, objectTitle=FDA批准首个每周1次长效生长激素疗法, objectType=article, longId=200198, objectId=a4b420019896, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/147963-medical-pills-capsules.jpg, objectUrl=/article/show_article.do?id=a4b420019896, replyNumber=0, likeNumber=87, createdTime=2020-09-03, rootId=0, userName=Psycho.Dr Du, userId=a8fb2299762, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4b420019896, moduleTitle=FDA批准首个每周1次长效生长激素疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4b420019896)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

医者仁者 (审核中...)

前往app查看评论内容

#生长激素缺乏症#

欧洲监管机构对Sogroya（somapacitan）治疗成人生长激素缺乏症持积极意见

2022-03-10

医者仁者 (审核中...)

前往app查看评论内容

#生长激素缺乏症#

成人生长激素缺乏症诊治专家共识（2020版）

2022-03-10

医者仁者 (审核中...)

前往app查看评论内容

#生长激素缺乏症#

针对生长激素缺乏症（GHD），FDA为Somatrogon发出了完整的回复信（CRL）

2022-03-10

医者仁者 (审核中...)

前往app查看评论内容

#生长激素缺乏症#

《过渡期生长激素缺乏症诊断及治疗专家共识》解读

2022-03-10

124fad42m35暂无昵称 (审核中...)

前往app查看评论内容

学习了#生长激素缺乏症#

2020 KES/KSPE立场声明：生长激素缺乏的诊断和治疗

2020-11-22

lovetcm (审核中...)

前往app查看评论内容

#生长激素缺乏症#

2020 KES/KSPE立场声明：生长激素缺乏的诊断和治疗

2020-10-29

lovetcm (审核中...)

前往app查看评论内容

#生长激素缺乏症#

过渡期生长激素缺乏症诊断及治疗专家共识

2020-10-29

lovetcm (审核中...)

前往app查看评论内容

#生长激素缺乏症#

长效生长激素Somatrogon治疗生长激素缺乏症儿童，日本3期临床成功

2020-10-29

Psycho.Dr Du (审核中...)

前往app查看评论内容

有点confused，请问生长激素缺乏症是不是就是呆小症？#生长激素缺乏症#🤔

FDA批准首个每周1次长效生长激素疗法

2020-09-03

科室
- - 订阅+
  - 更多科室
工具
服务